@NP	Reaction	1
@NP	Oligoglia	13
@NP	Spinal Cord Injury in Rats	26
@NP	Spinal Cord Injury	26
@NP	Rats	48
@NP	Transplantation of Human Olfactory Ensheathing Cells	57
@NP	Transplantation	57
@NP	Human Olfactory Ensheathing Cells	76
@NP	G.	111
@NP	A.	114
@NP	Masgutova1 , E.	117
@NP	Masgutova1	117
@NP	E.	129
@NP	A.	132
@NP	Savchenko2 , I.	135
@NP	Savchenko2	135
@NP	I.	147
@NP	V.	150
@NP	Viktorov2 , R.	153
@NP	Viktorov2	153
@NP	R.	164
@NP	F.	167
@NP	Masgutov1 , Yu .	170
@NP	Masgutov1	170
@NP	Yu	181
@NP	A.	185
@NP	Chelyshev1 ,3	188
@NP	Kletochnye Tehnologii v Biologii i Medicine	217
@NP	Kletochnye Tehnologii v	217
@NP	No. 1	262
@NP	27-31	273
@NP	January	280
@NP	2010 Original article	289
@NP	April 22 , 2009	321
@NP	experiments on rats with lateral TVIII hemisection of the spinal cord	340
@NP	experiments	340
@NP	rats with lateral TVIII hemisection of the spinal cord	355
@NP	rats	355
@NP	lateral TVIII hemisection of the spinal cord	365
@NP	lateral TVIII hemisection	365
@NP	the spinal cord	394
@NP	transplantation of ensheating olfactory cells	414
@NP	transplantation	414
@NP	olfactory cells	444
@NP	we	461
@NP	structural changes	472
@NP	the lesion site and adjacent rostral and dorsal regions of the spinal cord	494
@NP	the lesion site	494
@NP	adjacent rostral and dorsal regions of the spinal cord	514
@NP	adjacent rostral and dorsal regions	514
@NP	the spinal cord	553
@NP	The state	570
@NP	oligodendrocytes and myelin fi bers and motor function in experimental animal	583
@NP	oligodendrocytes and myelin fi bers	583
@NP	oligodendrocytes	583
@NP	myelin fi bers	604
@NP	motor function in experimental animal	623
@NP	motor function	623
@NP	experimental animal	641
@NP	Open fi	676
@NP	testing -LRB- BBB test -RRB-	688
@NP	testing	688
@NP	BBB test	697
@NP	motor functions	719
@NP	13 % on average	758
@NP	13 %	758
@NP	average	765
@NP	the interval from day 21 to day 53 after transplantation	781
@NP	the interval	781
@NP	day 21 to day 53 after transplantation	799
@NP	day 21	799
@NP	day 53 after transplantation	809
@NP	day 53	809
@NP	transplantation	822
@NP	Histological examination	839
@NP	groups	876
@NP	transplanted cells carrying human nuclear marker -LRB- HNu + cells -RRB-	886
@NP	transplanted cells	886
@NP	human nuclear marker -LRB- HNu + cells -RRB-	914
@NP	human nuclear marker	914
@NP	HNu + cells	936
@NP	HNu	936
@NP	cells	941
@NP	the lesion site	970
@NP	30 days	986
@NP	surgery	1000
@NP	Some of these cells	1009
@NP	Some	1009
@NP	these cells	1017
@NP	the rostral and caudal directions	1041
@NP	the rostral	1041
@NP	caudal directions	1057
@NP	the injection site	1080
@NP	a distance up to 6 mm	1102
@NP	a distance	1102
@NP	6 mm	1119
@NP	the initial period after hemisection	1128
@NP	the initial period	1128
@NP	hemisection	1153
@NP	the number	1166
@NP	oligodendrocytes -LRB- O4 + - cells -RRB-	1180
@NP	oligodendrocytes	1180
@NP	O4 + - cells	1198
@NP	O4 +	1198
@NP	O4	1198
@NP	+	1200
@NP	cells	1202
@NP	the immediate vicinity to the lesion site	1212
@NP	the immediate vicinity	1212
@NP	the lesion site	1238
@NP	no signifi cant changes in the number of neurons	1276
@NP	no signifi cant changes	1276
@NP	the number of neurons	1303
@NP	the number	1303
@NP	neurons	1317
@NP	the rostral and dorsal fragments of the spinal cord	1339
@NP	the rostral and dorsal fragments	1339
@NP	the spinal cord	1375
@NP	the corresponding parameter in controls	1403
@NP	the corresponding parameter	1403
@NP	controls	1434
@NP	Sixty days	1444
@NP	transplantation	1461
@NP	the cross-section area	1478
@NP	the rostral part of the spinal cord at a distance of 3 mm from damage site	1504
@NP	the rostral part	1504
@NP	the spinal cord at a distance of 3 mm from damage site	1524
@NP	the spinal cord	1524
@NP	a distance of 3 mm from damage site	1543
@NP	a distance	1543
@NP	3 mm from damage site	1557
@NP	3 mm	1557
@NP	damage site	1567
@NP	15.3 % compared to the control	1592
@NP	15.3 %	1592
@NP	the control	1610
@NP	The number	1623
@NP	O4	1637
@NP	cells at the lesion site and in adjacent rostral	1642
@NP	cells	1642
@NP	the lesion site	1651
@NP	adjacent rostral	1674
@NP	caudal parts of the spinal cord by 22.8 %	1695
@NP	caudal parts	1695
@NP	the spinal cord by 22.8 %	1711
@NP	the spinal cord	1711
@NP	22.8 %	1730
@NP	the control group	1754
@NP	The number of remyelinated axons	1773
@NP	The number	1773
@NP	axons	1800
@NP	These fi ndings	1822
@NP	These	1822
@NP	fi ndings	1828
@NP	the absence	1846
@NP	pronounced structural changes in the rostral and caudal parts of the spinal cord	1861
@NP	pronounced structural changes in the rostral	1861
@NP	pronounced structural changes	1861
@NP	the rostral	1894
@NP	caudal parts of the spinal cord	1910
@NP	caudal parts	1910
@NP	the spinal cord	1926
@NP	lesion site at early stages after damage and cell transplantation	1954
@NP	lesion site	1954
@NP	early stages after damage and cell transplantation	1969
@NP	early stages	1969
@NP	damage and cell transplantation	1988
@NP	the same time	2024
@NP	pronounced activation of oligodendrocytes in this region	2039
@NP	pronounced activation	2039
@NP	oligodendrocytes in this region	2064
@NP	oligodendrocytes	2064
@NP	this region	2084
@NP	their involvement	2105
@NP	Schwann cells	2137
@NP	remyelination	2156
@NP	regenerating axons	2173
@NP	a factor of partial restoration of motor functions	2212
@NP	a factor	2212
@NP	partial restoration of motor functions	2224
@NP	partial restoration	2224
@NP	motor functions	2247
@NP	spinal cord injury	2269
@NP	Traumatic injuries of the spinal cord	2290
@NP	Traumatic injuries	2290
@NP	the spinal cord	2312
@NP	local loss	2348
@NP	neurons and demyelination	2362
@NP	axons of ascending and descending spinal tracts	2391
@NP	axons	2391
@NP	spinal tracts	2425
@NP	Numerous experimental and clinical studies	2440
@NP	regeneration	2495
@NP	the spinal cord	2511
@NP	pharmacological agents and cell therapy	2556
@NP	pharmacological agents	2556
@NP	cell therapy	2583
@NP	regeneration	2616
@NP	damaged neurons	2632
@NP	new formation	2652
@NP	myelin sheath	2669
@NP	the preserved and regenerated fi bers	2690
@NP	the spinal tracts	2731
@NP	partial compensation of impaired motor and sensory functions -LSB- 7-9 -RSB-	2767
@NP	partial compensation of impaired motor	2767
@NP	partial compensation	2767
@NP	impaired motor	2791
@NP	sensory functions -LSB- 7-9 -RSB-	2810
@NP	sensory functions	2810
@NP	7-9 -RSB-	2829
@NP	these studies	2838
@NP	the most contradictory issue	2853
@NP	conception	2885
@NP	the recovery	2907
@NP	myelin sheaths	2923
@NP	transplantation	2960
@NP	glial cells from the olfactory system -LRB- olfactory ensheating cells -RRB-	2979
@NP	glial cells from the olfactory system	2979
@NP	glial cells	2979
@NP	the olfactory system	2996
@NP	olfactory ensheating cells	3018
@NP	data	3067
@NP	the role of these cells in remyelination	3075
@NP	the role	3075
@NP	these cells in remyelination	3087
@NP	these cells	3087
@NP	remyelination	3102
@NP	spinal lesion	3122
@NP	11 -RSB-	3137
@NP	later studies	3164
@NP	the main role	3185
@NP	Schwann cells -LSB- 10,13 -RSB-	3215
@NP	Schwann cells	3215
@NP	10,13 -RSB-	3230
@NP	the same time	3241
@NP	the data	3256
@NP	the state of oligodendroglia	3271
@NP	the state	3271
@NP	oligodendroglia	3284
@NP	its involvement	3304
@NP	remyelination	3325
@NP	spinal cord tract fi bers outside the damaged area during cell therapy	3342
@NP	spinal cord tract fi bers	3342
@NP	the damaged area during cell therapy	3376
@NP	the damaged area	3376
@NP	cell therapy	3400
@NP	we	3441
@NP	the state of oligodendrocytes in damaged spinal cord and their role	3452
@NP	the state	3452
@NP	oligodendrocytes in damaged spinal cord and their role	3465
@NP	oligodendrocytes	3465
@NP	damaged spinal cord and their role	3485
@NP	damaged spinal cord	3485
@NP	their role	3509
@NP	regeneration of myelin sheaths	3523
@NP	regeneration	3523
@NP	myelin sheaths	3539
@NP	transplantation of olfactory epithelium cells	3560
@NP	transplantation	3560
@NP	olfactory epithelium cells	3579
@NP	MATERIALS AND METHODS Experiments	3608
@NP	MATERIALS	3608
@NP	METHODS Experiments	3622
@NP	14 mongrel rats	3662
@NP	weighted 200-250 g.	3678
@NP	The animals	3698
@NP	standard conditions	3726
@NP	free access	3751
@NP	food and water	3766
@NP	laminectomy under urethane anesthesia -LRB- 600 mg / kg intraperitoneally -RRB-	3788
@NP	laminectomy	3788
@NP	urethane anesthesia -LRB- 600 mg / kg intraperitoneally -RRB-	3806
@NP	urethane anesthesia	3806
@NP	600 mg / kg intraperitoneally	3827
@NP	600	3827
@NP	mg / kg intraperitoneally	3831
@NP	mg / kg	3831
@NP	mg	3831
@NP	kg	3835
@NP	local hemisection of the spinal cord at the right side at TVIII level	3858
@NP	local hemisection	3858
@NP	the spinal cord at the right side at TVIII level	3879
@NP	the spinal cord	3879
@NP	the right side at TVIII level	3898
@NP	the right side	3898
@NP	TVIII level	3916
@NP	This method of hemisection	3943
@NP	This method	3943
@NP	hemisection	3958
@NP	the undamaged side	3984
@NP	the spinal cord	4006
@NP	evaluation of the character and extent of posttraumatic processes	4026
@NP	evaluation	4026
@NP	the character and extent of posttraumatic processes	4040
@NP	the character and extent	4040
@NP	posttraumatic processes	4068
@NP	the damaged area	4095
@NP	Olfactory epithelium -LRB- OE -RRB- cells	4113
@NP	Olfactory epithelium	4113
@NP	OE	4135
@NP	transplantation	4159
@NP	the cells	4176
@NP	Department of Applied and Fundamental Neurology -LRB- V.	4205
@NP	Department	4205
@NP	Applied and Fundamental Neurology -LRB- V.	4219
@NP	Applied	4219
@NP	Neurology -LRB- V.	4243
@NP	P.	4257
@NP	Serbskii Research Center	4260
@NP	Social and Forensic Psychiatry -RRB-	4288
@NP	cultured as described previously -LSB- 1 -RSB-	4324
@NP	1	4358
@NP	hemisection	4368
@NP	200,000 cells in 5 μl Ringer solution	4381
@NP	200,000 cells	4381
@NP	5 μl Ringer solution	4398
@NP	experimental group animals -LRB- n = 8 -RRB- in two points 1 mm rostrally	4436
@NP	experimental group animals -LRB- n = 8 -RRB-	4436
@NP	experimental group animals	4436
@NP	n	4464
@NP	8	4466
@NP	two points 1 mm rostrally	4472
@NP	two points	4472
@NP	1 mm	4483
@NP	the hemisection plane and 0.5 mm	4516
@NP	the hemisection plane	4516
@NP	0.5 mm	4542
@NP	the midline towards the damaged side	4564
@NP	the midline	4564
@NP	the damaged side	4584
@NP	Control animals -LRB- n = 6 -RRB-	4602
@NP	Control animals	4602
@NP	n	4619
@NP	6	4621
@NP	5 μl Ringer solution	4633
@NP	the same points	4657
@NP	Locomotor function in control and experimental animals	4674
@NP	Locomotor function	4674
@NP	control and experimental animals	4696
@NP	day 2 to day 53 in the open fi	4767
@NP	day 2	4767
@NP	day 53 in the open fi	4776
@NP	day 53	4776
@NP	the open fi	4786
@NP	eld test -LRB- BBB test -RRB- -LSB- 2 -RSB-	4798
@NP	eld test	4798
@NP	BBB test	4808
@NP	2 -RSB-	4819
@NP	The data	4823
@NP	ANOVA and Mann -- Whitney test	4867
@NP	ANOVA and Mann	4867
@NP	Whitney test	4882
@NP	Histological and immunocytochemical examination	4896
@NP	the spinal cords from the experimental and control animals	4947
@NP	the spinal cords	4947
@NP	the experimental and control animals	4969
@NP	30 and 60 days after the intervention	5019
@NP	30 and 60 days	5019
@NP	the intervention	5040
@NP	Anaesthetized animals	5058
@NP	phosphate buffer -LRB- pH 7.4 -RRB-	5114
@NP	phosphate buffer	5114
@NP	pH 7.4	5132
@NP	4 % paraformaldehyde on phosphate buffer	5154
@NP	4 % paraformaldehyde	5154
@NP	phosphate buffer	5177
@NP	laminectomy	5201
@NP	a 20-mm fragment of the spinal cord with hemisection plane in the center	5214
@NP	a 20-mm fragment	5214
@NP	the spinal cord with hemisection plane in the center	5234
@NP	the spinal cord	5234
@NP	hemisection plane in the center	5255
@NP	hemisection plane	5255
@NP	the center	5276
@NP	The material	5301
@NP	neutral formalin or glutaraldehyde	5341
@NP	paraffi n and a mixture of epon and araldite resin	5392
@NP	paraffi n	5392
@NP	a mixture of epon and araldite resin	5406
@NP	a mixture	5406
@NP	epon and araldite resin	5419
@NP	standard techniques	5456
@NP	cross-sections stained with methylene blue	5480
@NP	cross-sections	5480
@NP	methylene blue	5508
@NP	the total area of section	5524
@NP	the total area	5524
@NP	section	5542
@NP	area of the damaged site	5551
@NP	area	5551
@NP	the damaged site	5559
@NP	area of preserved grey matter	5581
@NP	area	5581
@NP	preserved grey matter	5589
@NP	the distance from 1 mm	5628
@NP	the distance	5628
@NP	1 mm	5646
@NP	10 mm caudally and rostrally	5654
@NP	10 mm	5654
@NP	the hemisection plane -LSB- 12 -RSB-	5688
@NP	the hemisection plane	5688
@NP	12 -RSB-	5711
@NP	day 60 after the intervention	5719
@NP	day 60	5719
@NP	the intervention	5732
@NP	the number of neurons	5750
@NP	the number	5750
@NP	neurons	5764
@NP	sections stained with methylene blue	5790
@NP	sections	5790
@NP	methylene blue	5812
@NP	The number of oligodendrocytes	5828
@NP	The number	5828
@NP	oligodendrocytes	5842
@NP	immunohistochemical reaction	5880
@NP	O4 antibodies -LRB- 1:100 , R&D Systems , Inc. -RRB-	5914
@NP	O4 antibodies	5914
@NP	1:100	5929
@NP	R&D Systems	5936
@NP	Inc.	5949
@NP	red fl uorescent label Cy3 -LRB- 1:300 , Dianova -RRB-	5960
@NP	red fl uorescent label Cy3	5960
@NP	1:300 , Dianova	5988
@NP	1:300	5988
@NP	Dianova	5995
@NP	nucleus identifi cation	6009
@NP	the sections	6034
@NP	a medium with fl uorescent	6065
@NP	a medium	6065
@NP	fl uorescent	6079
@NP	Dapi -LRB- 1:1000 ; Dianova -RRB-	6096
@NP	Dapi	6096
@NP	1:1000 ; Dianova	6102
@NP	1:1000	6102
@NP	Dianova	6110
@NP	The number of myelin fi bers	6120
@NP	The number	6120
@NP	myelin fi bers	6134
@NP	a distance of 5 mm rostrally and caudally from the hemisection plane	6167
@NP	a distance	6167
@NP	5 mm	6181
@NP	the hemisection plane	6214
@NP	staining of semithin sections of the spinal cord with toluidine blue	6242
@NP	staining	6242
@NP	semithin sections of the spinal cord with toluidine blue	6254
@NP	semithin sections	6254
@NP	the spinal cord with toluidine blue	6275
@NP	the spinal cord	6275
@NP	toluidine blue	6296
@NP	Migration	6312
@NP	cells	6325
@NP	antibodies	6344
@NP	human cell nuclei -LRB- HNu , 1:100 , Chemicon -RRB-	6358
@NP	human cell nuclei	6358
@NP	HNu	6377
@NP	1:100	6382
@NP	Chemicon	6389
@NP	30 days	6413
@NP	their transplantation	6427
@NP	the site of damage	6454
@NP	the site	6454
@NP	damage	6466
@NP	Immunocytochemical examination	6474
@NP	an Axioscope 2 fl uorescent microscope and Image J software	6525
@NP	an Axioscope 2 fl	6525
@NP	uorescent microscope and Image J software	6543
@NP	Statistical signifi cance of obtained data	6586
@NP	Statistical signifi cance	6586
@NP	obtained data	6615
@NP	ANOVA , Mann -- Whitney , and Student tests	6648
@NP	ANOVA	6648
@NP	Mann -- Whitney	6655
@NP	Mann	6655
@NP	Whitney	6661
@NP	Student tests	6674
@NP	RESULTS	6690
@NP	1	6703
@NP	human OE cells	6719
@NP	rat spinal cord	6737
@NP	immunohistochemical reaction	6754
@NP	antibodies to human cell nuclei -LRB- HNu -RRB- 30 days	6788
@NP	antibodies	6788
@NP	human cell nuclei -LRB- HNu -RRB-	6802
@NP	human cell nuclei	6802
@NP	HNu	6821
@NP	30 days	6826
@NP	intervention	6840
@NP	Distance	6854
@NP	hemisection plane	6868
@NP	the rostral direction : a -RRB- 1 mm , b -RRB- 3 mm , c -RRB- 5 mm , d -RRB- 7	6893
@NP	direction : a	6905
@NP	direction	6905
@NP	a	6916
@NP	1 mm , b	6919
@NP	1 mm	6919
@NP	b	6925
@NP	3 mm , c	6928
@NP	3 mm	6928
@NP	c	6934
@NP	5 mm , d	6937
@NP	5 mm	6937
@NP	d	6943
@NP	mm	6948
@NP	Fig. 2 .	6953
@NP	Fig.	6953
@NP	2	6958
@NP	Morphometric characteristics of rat	6961
@NP	Morphometric characteristics	6961
@NP	rat	6993
@NP	spinal cord	6997
@NP	30 -LRB- a , b -RRB- and 60 days -LRB- c , d -RRB-	7009
@NP	30 -LRB- a , b -RRB-	7009
@NP	30	7009
@NP	a , b	7013
@NP	a	7013
@NP	b	7016
@NP	60 days -LRB- c , d -RRB-	7023
@NP	transplantation of human OE cells in the site of hemisection	7044
@NP	transplantation	7044
@NP	human OE cells in the site of hemisection	7063
@NP	human OE cells	7063
@NP	the site of hemisection	7081
@NP	the site	7081
@NP	hemisection	7093
@NP	a , c -RRB- area of preserved grey matter ; b , d -RRB- area of damaged site .	7106
@NP	a , c -RRB- area of preserved grey matter	7106
@NP	a , c -RRB- area	7106
@NP	a , c -RRB-	7106
@NP	a	7106
@NP	preserved grey matter	7120
@NP	b , d -RRB- area of damaged site	7143
@NP	b , d -RRB- area	7143
@NP	damaged site	7157
@NP	Abscissa	7171
@NP	distance	7181
@NP	hemisection plane	7195
@NP	+	7225
@NP	and caudal -LRB- - -RRB- directions in mm	7228
@NP	and caudal	7228
@NP	directions in mm	7243
@NP	directions	7243
@NP	mm	7257
@NP	a and c	7264
@NP	control	7276
@NP	values -LRB- without cell injection -RRB- ,	7284
@NP	values -LRB- without cell injection -RRB-	7284
@NP	values	7284
@NP	cell injection	7300
@NP	2 -RRB- experimental values -LRB- cell injection	7317
@NP	2 -RRB- experimental values -LRB- cell	7317
@NP	experimental values	7320
@NP	cell	7341
@NP	injection	7346
@NP	b and d	7361
@NP	light bars : control , dark bars : experimental group	7370
@NP	light bars	7370
@NP	control , dark bars	7382
@NP	control	7382
@NP	dark bars	7391
@NP	experimental group	7402
@NP	Fig. 3 .	7423
@NP	Fig.	7423
@NP	3	7428
@NP	The number	7431
@NP	O4	7445
@NP	cells in rat spinal cord at a distance of 3 mm in the caudal -LRB- 1 -RRB-	7449
@NP	cells	7449
@NP	rat spinal cord at a distance of 3 mm in the caudal -LRB- 1 -RRB-	7458
@NP	rat spinal cord	7458
@NP	a distance of 3 mm in the caudal -LRB- 1 -RRB-	7477
@NP	a distance	7477
@NP	3 mm in the caudal -LRB- 1 -RRB-	7491
@NP	3 mm	7491
@NP	the caudal -LRB- 1 -RRB-	7499
@NP	the caudal	7499
@NP	1	7511
@NP	rostral -LRB- 2 -RRB- directions	7518
@NP	rostral	7518
@NP	2	7527
@NP	directions	7530
@NP	the hemisection plane 60 days after intervention	7546
@NP	the hemisection plane	7546
@NP	60 days	7568
@NP	intervention	7582
@NP	Ordinate : total number of cells on the section ; light bars	7596
@NP	Ordinate	7596
@NP	total number of cells on the section	7606
@NP	total number	7606
@NP	cells on the section	7622
@NP	cells	7622
@NP	the section	7631
@NP	light bars	7644
@NP	control , dark bars : experiment	7656
@NP	control	7656
@NP	dark bars	7665
@NP	experiment	7676
@NP	line	7695
@NP	number of O4 + - cells in the spinal cord of intact animals at TVIII level	7701
@NP	number of O4	7701
@NP	number	7701
@NP	O4	7711
@NP	- cells in the spinal cord of intact animals at TVIII level	7714
@NP	cells	7715
@NP	the spinal cord of intact animals at TVIII level	7724
@NP	the spinal cord	7724
@NP	intact animals	7743
@NP	TVIII	7761
@NP	level	7767
@NP	Fig. 4 : * p < 0.05 when control and experimental values are compared	7786
@NP	Fig. 4	7786
@NP	p <	7795
@NP	p	7795
@NP	<	7796
@NP	0.05	7797
@NP	control and experimental values	7807
@NP	control	7807
@NP	experimental values	7819
@NP	Fig. 4 .	7854
@NP	Fig.	7854
@NP	4	7859
@NP	Dynamics	7862
@NP	recovery	7874
@NP	motor function	7886
@NP	field test -LRB- BBB test -RRB-	7919
@NP	field test	7919
@NP	BBB test	7931
@NP	hemisection of rat spinal cord	7947
@NP	hemisection	7947
@NP	rat spinal cord	7962
@NP	injection	7982
@NP	human OE cells	7995
@NP	the site	8015
@NP	damage	8027
@NP	1 -RRB- control ; 2 -RRB- experimental group .	8035
@NP	control	8038
@NP	2 -RRB- experimental group	8047
@NP	Thirty days	8071
@NP	spinal cord hemisection and transplantation of OE cells	8089
@NP	spinal cord hemisection and transplantation	8089
@NP	OE cells	8136
@NP	groups of cells	8146
@NP	groups	8146
@NP	cells	8156
@NP	human nucleus marker -LRB- HNu + - cells -RRB-	8175
@NP	human nucleus marker	8175
@NP	HNu + - cells	8197
@NP	HNu +	8197
@NP	HNu	8197
@NP	+	8200
@NP	cells	8202
@NP	the zone of damage -LRB- Fig. 1 -RRB-	8223
@NP	the zone	8223
@NP	damage -LRB- Fig. 1 -RRB-	8235
@NP	damage	8235
@NP	Fig. 1	8243
@NP	We	8252
@NP	these cells	8267
@NP	the distance of 6.20 ± 1.23 mm in the rostral direction	8294
@NP	the distance	8294
@NP	6.20	8310
@NP	the rostral direction	8326
@NP	5.80 ±	8358
@NP	1.08 mm in the caudal direction	8363
@NP	1.08 mm	8363
@NP	the caudal direction	8374
@NP	the spinal cord	8403
@NP	previously obtained data	8442
@NP	glial cells	8468
@NP	OE	8485
@NP	the spinal cord start	8504
@NP	4 h	8537
@NP	transplantation	8547
@NP	day 7	8570
@NP	a distance	8581
@NP	1 mm in both rostral and caudal directions	8601
@NP	1 mm	8601
@NP	both rostral and caudal directions	8609
@NP	rostral	8614
@NP	caudal directions	8626
@NP	4 -RSB-	8645
@NP	injection of OE cells into the site of hemisection	8655
@NP	injection	8655
@NP	OE cells into the site of hemisection	8668
@NP	OE cells	8668
@NP	the site of hemisection	8682
@NP	the site	8682
@NP	hemisection	8694
@NP	the area of damage	8707
@NP	the area	8707
@NP	damage	8719
@NP	the control on days 30 and 60	8746
@NP	the control	8746
@NP	days 30 and 60	8761
@NP	Signifi cant changes in the area of damage	8777
@NP	Signifi cant changes	8777
@NP	the area of damage	8801
@NP	the area	8801
@NP	damage	8813
@NP	7 mm	8834
@NP	the damage site	8854
@NP	30 days	8870
@NP	intervention	8884
@NP	Fig. 2	8898
@NP	b	8906
@NP	Sixty days	8910
@NP	transplantation	8927
@NP	the cross-section area	8944
@NP	a distance of 3 mm rostrally from the hemisection plane	8970
@NP	a distance	8970
@NP	3 mm rostrally from the hemisection plane	8984
@NP	3 mm	8984
@NP	the hemisection plane	9004
@NP	control animals	9044
@NP	15.3 %	9063
@NP	p < 0.05	9070
@NP	p	9070
@NP	< 0.05	9071
@NP	<	9071
@NP	0.05	9072
@NP	The area of preserved grey matter	9079
@NP	The area	9079
@NP	preserved grey matter	9091
@NP	30 and 60 days after transplantation of OE cells -LRB- Fig. 2 , a , c -RRB-	9137
@NP	30 and 60 days	9137
@NP	transplantation of OE cells -LRB- Fig. 2 , a , c -RRB-	9158
@NP	transplantation	9158
@NP	OE cells -LRB- Fig. 2 , a , c -RRB-	9177
@NP	OE cells	9177
@NP	Fig. 2	9187
@NP	a , c	9195
@NP	a	9195
@NP	c	9198
@NP	The number of O4 + cells in the immediate proximity to the site of damage	9202
@NP	The number	9202
@NP	O4 + cells in the immediate proximity to the site of damage	9216
@NP	O4 + cells	9216
@NP	the immediate proximity to the site of damage	9229
@NP	the immediate proximity	9229
@NP	the site of damage	9256
@NP	the site	9256
@NP	damage	9268
@NP	day 60 -LRB- Fig. 3 -RRB-	9303
@NP	day 60	9303
@NP	Fig. 3	9311
@NP	the number of O4	9326
@NP	the number	9326
@NP	O4	9340
@NP	cells at a distance of 3 mm	9344
@NP	cells	9344
@NP	a distance of 3 mm	9353
@NP	a distance	9353
@NP	3 mm	9367
@NP	the hemisection plane at this term	9387
@NP	the hemisection plane	9387
@NP	this term	9412
@NP	the corresponding parameter	9431
@NP	control animals	9462
@NP	22.8 % -LRB- p < 0.05 , Fig. 3 -RRB-	9481
@NP	22.8 %	9481
@NP	p	9488
@NP	< 0.05 , Fig. 3	9489
@NP	<	9489
@NP	0.05	9490
@NP	Fig. 3	9496
@NP	These data	9505
@NP	such substantial results of cell therapy of spinal cord injuries	9548
@NP	such substantial results	9548
@NP	cell therapy of spinal cord injuries	9576
@NP	cell therapy	9576
@NP	spinal cord injuries	9592
@NP	maintenance of oligodendrocyte structure and function	9616
@NP	maintenance	9616
@NP	oligodendrocyte structure and function	9631
@NP	inhibition of posttraumatic demyelination	9671
@NP	inhibition	9671
@NP	posttraumatic demyelination	9685
@NP	stimulation of remyelination of nerve fi bers	9718
@NP	stimulation	9718
@NP	remyelination of nerve fi bers	9733
@NP	remyelination	9733
@NP	nerve fi bers	9750
@NP	Motor function in the experimental animals	9765
@NP	Motor function	9765
@NP	the experimental animals	9783
@NP	21 day to 53 day after he	9838
@NP	21 day	9838
@NP	53 day after he	9848
@NP	53 day	9848
@NP	he	9861
@NP	misection and transplantation of human OE cells	9864
@NP	misection and transplantation	9864
@NP	human OE cells	9897
@NP	this period	9920
@NP	motor function in rats receiving transplantation of OE	9933
@NP	motor function	9933
@NP	rats receiving transplantation of OE	9951
@NP	rats	9951
@NP	transplantation of OE	9966
@NP	transplantation	9966
@NP	OE	9985
@NP	BBB test	10021
@NP	12.8 % on average	10033
@NP	12.8 %	10033
@NP	average	10042
@NP	comparison with control animals -LRB- Fig. 4 -RRB-	10054
@NP	comparison	10054
@NP	control animals -LRB- Fig. 4 -RRB-	10070
@NP	control animals	10070
@NP	Fig. 4	10087
@NP	Our results	10096
@NP	previous data obtained in similar studies -LSB- 8 -RSB-	10119
@NP	previous data	10119
@NP	similar studies -LSB- 8 -RSB-	10145
@NP	similar studies	10145
@NP	8 -RSB-	10162
@NP	It	10166
@NP	the described improvement in motor functions	10199
@NP	the described improvement	10199
@NP	motor functions	10228
@NP	an increase in oligodendrocyte number	10269
@NP	an increase	10269
@NP	oligodendrocyte number	10284
@NP	spinal cord regeneration	10314
@NP	These data	10340
@NP	the basis	10364
@NP	the role of oligodendroglia	10392
@NP	the role	10392
@NP	oligodendroglia	10404
@NP	one of major regeneration processes	10423
@NP	one	10423
@NP	major regeneration processes	10430
@NP	cell therapy of spinal cord lesions	10466
@NP	cell therapy	10466
@NP	spinal cord lesions	10482
@NP	inhibition of demyelination of impaired nerve fi bers	10503
@NP	inhibition	10503
@NP	demyelination of impaired nerve fi bers	10517
@NP	demyelination	10517
@NP	impaired nerve fi bers	10534
@NP	simulation of remyelination of regenerating axons in spinal tracts	10561
@NP	simulation	10561
@NP	remyelination of regenerating axons in spinal tracts	10575
@NP	remyelination	10575
@NP	regenerating axons in spinal tracts	10592
@NP	regenerating axons	10592
@NP	spinal tracts	10614
@NP	The increase	10629
@NP	the number	10645
@NP	oligodendrocytes	10659
@NP	transplantation of olfactory epithelium cells into the damaged spinal cord	10682
@NP	transplantation	10682
@NP	olfactory epithelium cells into the damaged spinal cord	10701
@NP	olfactory epithelium cells	10701
@NP	the damaged spinal cord	10733
@NP	production of neurotrophic factors essential for oligodendrocyte survival	10777
@NP	production	10777
@NP	neurotrophic factors essential for oligodendrocyte survival	10791
@NP	neurotrophic factors	10791
@NP	oligodendrocyte survival	10826
@NP	transplanted cells	10854
@NP	appreciable distances in the undamaged rostral	10886
@NP	appreciable distances	10886
@NP	the undamaged rostral	10911
@NP	caudal parts of the spinal cord	10937
@NP	caudal parts	10937
@NP	the spinal cord	10953
@NP	The possibility	10970
@NP	stimulation	10989
@NP	differentiation and proliferation	11004
@NP	oligodendrocyte progenitors by transplanted cells	11041
@NP	oligodendrocyte progenitors	11041
@NP	transplanted cells	11072
@NP	6 -RSB-	11116
@NP	Remyelination of regenerated axons by Schwann cells after spinal cord damage	11120
@NP	Remyelination	11120
@NP	regenerated axons by Schwann cells after spinal cord damage	11137
@NP	regenerated axons	11137
@NP	Schwann cells after spinal cord damage	11158
@NP	Schwann cells	11158
@NP	spinal cord damage	11178
@NP	a number of reports	11213
@NP	a number	11213
@NP	reports	11225
@NP	these studies	11247
@NP	glial cells	11274
@NP	myelin sheaths	11298
@NP	migration of Schwann cells	11328
@NP	migration	11328
@NP	Schwann cells	11341
@NP	the area of spinal cord damage	11360
@NP	the area	11360
@NP	spinal cord damage	11372
@NP	microenvironment	11402
@NP	ber myelination	11436
@NP	Schwann cells -LSB- 3,5,10,13	11455
@NP	Schwann cells	11455
@NP	3,5,10,13	11470
@NP	our fi ndings and previously obtained results	11501
@NP	our fi ndings	11501
@NP	previously obtained results	11519
@NP	remyelination	11548
@NP	spinal tracts	11590
@NP	axons	11621
@NP	the site of spinal cord damage	11630
@NP	the site	11630
@NP	spinal cord damage	11642
@NP	cell therapy	11668
@NP	trophic interaction	11696
@NP	transplanted glial OE cells	11724
@NP	myelin-producing oligodendroglial cells	11753
@NP	Schwann cells	11798
@NP	The study	11813
@NP	Russian Foundation	11840
@NP	Basic Research -LRB- grants No. 07-04-00746 , No. 08 - 04-01167 -RRB-	11863
@NP	Basic Research	11863
@NP	grants No. 07-04-00746	11879
@NP	grants	11879
@NP	No. 07-04-00746	11886
@NP	No. 08 - 04-01167	11903
@NP	No. 08	11903
@NP	04-01167	11911
@NP	DZN 09-15	11925
@VP	Translated from Kletochnye Tehnologii v Biologii i Medicine	201
@VP	ensheating olfactory cells	433
@VP	were analyzed	661
@VP	analyzed	666
@VP	carrying human nuclear marker -LRB- HNu + cells -RRB-	905
@VP	were still present at the lesion site 30 days after surgery	948
@VP	decreased 2-fold	1254
@VP	increased by 15.3 % compared to the control	1579
@VP	surpassed that in the control group	1736
@VP	remyelinated axons	1787
@VP	increased	1811
@VP	ascending and descending spinal tracts	2400
@VP	spontaneous and inducted by pharmacological agents and cell therapy	2528
@VP	obtained data on the role of these cells in remyelination after spinal lesion	3058
@VP	confi rmed in later studies	3150
@VP	rmed in later studies	3156
@VP	was assigned to Schwann cells -LSB- 10,13 -RSB-	3199
@VP	assigned to Schwann cells -LSB- 10,13 -RSB-	3203
@VP	are extremely limited	3413
@VP	were carried out on 14 mongrel rats weighted 200-250 g.	3642
@VP	carried out on 14 mongrel rats weighted 200-250 g.	3647
@VP	were kept under standard conditions with free access to food and water	3710
@VP	kept under standard conditions with free access to food and water	3715
@VP	was performed	3928
@VP	performed	3932
@VP	were used for transplantation	4145
@VP	used for transplantation	4150
@VP	were obtained from Department of Applied and Fundamental Neurology -LRB- V.	4186
@VP	obtained from Department of Applied and Fundamental Neurology -LRB- V.	4191
@VP	described previously -LSB- 1	4336
@VP	received 5 μl Ringer solution at the same points	4624
@VP	were processed statistically using ANOVA and Mann -- Whitney test	4832
@VP	processed statistically using ANOVA and Mann -- Whitney test	4837
@VP	using ANOVA and Mann -- Whitney test	4861
@VP	were carried 30 and 60 days after the intervention	5006
@VP	carried 30 and 60 days after the intervention	5011
@VP	was isolated	5287
@VP	isolated	5291
@VP	xed in neutral formalin or glutaraldehyde	5334
@VP	embedded in paraffi n and a mixture of epon and araldite resin	5380
@VP	stained with methylene blue	5495
@VP	was calculated on sections stained with methylene blue	5772
@VP	calculated on sections stained with methylene blue	5776
@VP	stained with methylene blue	5799
@VP	incubated in a medium with fl uorescent dye Dapi -LRB- 1:1000 ; Dianova -RRB-	6052
@VP	dye Dapi -LRB- 1:1000 ; Dianova -RRB-	6092
@VP	stained with antibodies to human cell nuclei -LRB- HNu , 1:100 , Chemicon -RRB-	6331
@VP	was evaluated 30 days after their transplantation into the site of damage	6399
@VP	evaluated 30 days after their transplantation into the site of damage	6403
@VP	was performed using an Axioscope 2 fl uorescent microscope and Image J software	6505
@VP	performed using an Axioscope 2 fl uorescent microscope and Image J software	6509
@VP	using an Axioscope 2 fl uorescent microscope and Image J software	6519
@VP	was assessed using ANOVA , Mann -- Whitney , and Student tests	6629
@VP	assessed using ANOVA , Mann -- Whitney , and Student tests	6633
@VP	using ANOVA , Mann -- Whitney , and Student tests	6642
@VP	Fig. 1	6698
@VP	rostral -LRB- + -RRB- and caudal -LRB- - -RRB- directions in mm	7216
@VP	-LRB- - -RRB- directions in mm	7239
@VP	are compared	7839
@VP	compared	7843
@VP	to open field test -LRB- BBB test -RRB- after hemisection of rat spinal cord	7911
@VP	open field test -LRB- BBB test -RRB- after hemisection of rat spinal cord	7914
@VP	were found in the zone of damage -LRB- Fig. 1 -RRB-	8209
@VP	found in the zone of damage -LRB- Fig. 1 -RRB-	8214
@VP	to migrate 4 h after transplantation and by day 7	8526
@VP	migrate 4 h after transplantation and by day 7	8529
@VP	-LSB- 4 -RSB-	8644
@VP	was smaller than in the control on days 30 and 60	8726
@VP	surpassed that in control animals by 15.3 % -LRB- p < 0.05 -RRB-	9026
@VP	decreased almost twofold on day 60 -LRB- Fig. 3 -RRB- , while the number of O4	9275
@VP	receiving transplantation of OE	9956
@VP	agree with previous data obtained in similar studies -LSB- 8 -RSB-	10108
@VP	obtained in similar studies -LSB- 8 -RSB-	10133
@VP	to be emphasized	10176
@VP	be emphasized	10179
@VP	emphasized	10182
@VP	can not also be excluded -LSB- 6 -RSB-	11091
@VP	be excluded -LSB- 6 -RSB-	11103
@VP	excluded -LSB- 6 -RSB-	11106
@VP	is described in a number of reports	11197
@VP	described in a number of reports	11200
@VP	transported glial cells	11262
@VP	form myelin sheaths	11293
@VP	stimulate migration of Schwann cells into the area of spinal cord damage	11318
@VP	maintaining fi - ber myelination by Schwann cells -LSB- 3,5,10,13 -RSB-	11419
@VP	ascending and descending spinal tracts	11565
@VP	regenerating axons at the site of spinal cord damage during cell therapy	11608
